Cargando…

Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model

Invasive pulmonary aspergillosis (IPA) is a life-threatening fungal infection occurring mainly in immunocompromised patients. We recently identified IPA as an emerging co-infection with high mortality in critically ill, but otherwise immunocompetent influenza patients. The neuraminidase inhibitor os...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seldeslachts, Laura, Vanderbeke, Lore, Fremau, Astrid, Reséndiz-Sharpe, Agustin, Jacobs, Cato, Laeveren, Bo, Ostyn, Tessa, Naesens, Lieve, Brock, Matthias, Van De Veerdonk, Frank L., Humblet-Baron, Stephanie, Verbeken, Erik, Lagrou, Katrien, Wauters, Joost, Vande Velde, Greetje
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923074/ https://www.ncbi.nlm.nih.gov/pubmed/34546839 http://dx.doi.org/10.1080/21505594.2021.1974327

Ejemplares similares

Overcome Double Trouble: Baloxavir Marboxil Suppresses Influenza Thereby Mitigating Secondary Invasive Pulmonary Aspergillosis
por: Seldeslachts, Laura, et al.
Publicado: (2021)

A Pathology-based Case Series of Influenza- and COVID-19–associated Pulmonary Aspergillosis: The Proof Is in the Tissue
por: Vanderbeke, Lore, et al.
Publicado: (2023)

Longitudinal multimodal imaging-compatible mouse model of triazole-sensitive and -resistant invasive pulmonary aspergillosis
por: Resendiz-Sharpe, Agustin, et al.
Publicado: (2022)

967. Inhibition of Host Neuraminidase Increases Susceptibility to Invasive Pulmonary Aspergillosis
por: Van De Veerdonk, Frank, et al.
Publicado: (2018)

Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study
por: Feys, Simon, et al.
Publicado: (2022)

Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis
por: Dewi, Intan M.W., et al.
Publicado: (2021)

S3.3d Influenza versus COVID-19-associated pulmonary aspergillosis: Profiling lower respiratory tract epithelial and myeloid innate immunity in patient samples
por: Feys, Simon, et al.
Publicado: (2022)

Powerful and Real-Time Quantification of Antifungal Efficacy against Triazole-Resistant and -Susceptible Aspergillus fumigatus Infections in Galleria mellonella by Longitudinal Bioluminescence Imaging
por: Vanhoffelen, Eliane, et al.
Publicado: (2023)

Quantitative PCR Effectively Quantifies Triazole-Susceptible and Triazole-Resistant Aspergillus fumigatus in Mixed Infections
por: Resendiz-Sharpe, Agustin, et al.
Publicado: (2022)

Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis
por: Janssen, Nico A.F., et al.
Publicado: (2021)

A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Feys, Simon, et al.
Publicado: (2021)

Longitudinal In Vivo Assessment of Host-Microbe Interactions in a Murine Model of Pulmonary Aspergillosis
por: Saini, Shweta, et al.
Publicado: (2019)

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial
por: Vanderbeke, Lore, et al.
Publicado: (2021)

Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
por: Verweij, Paul E., et al.
Publicado: (2020)

Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age
por: Mercier, Toine, et al.
Publicado: (2018)

Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study
por: Wauters, Joost, et al.
Publicado: (2012)

Does Pulmonary Aspergillosis Complicate Coronavirus Disease 2019?
por: Beer, Karlyn D., et al.
Publicado: (2020)

Influenza Coinfection: Be(a)ware of Invasive Aspergillosis
por: Verweij, Paul E, et al.
Publicado: (2020)

Increased IL‐10‐producing regulatory T cells are characteristic of severe cases of COVID‐19
por: Neumann, Julika, et al.
Publicado: (2020)

CryptoCEST: A promising tool for spatially resolved identification of fungal brain lesions and their differentiation from brain tumors with MRI
por: Vanherp, Liesbeth, et al.
Publicado: (2021)

A Mortality Prediction Rule for Hematology Patients with Invasive Aspergillosis Based on Serum Galactomannan Kinetics
por: Mercier, Toine, et al.
Publicado: (2020)

Lung Functioning and Inflammation in a Mouse Model of Systemic Juvenile Idiopathic Arthritis
por: Malengier-Devlies, Bert, et al.
Publicado: (2021)

Successful Multimodal Therapy with Intracerebral Liposomal Amphotericin B and Systemic High-Dose Isavuconazole in Proven Disseminated Aspergillosis
por: Feys, Simon, et al.
Publicado: (2023)

Bronchoscopic fibered confocal fluorescence microscopy for longitudinal in vivo assessment of pulmonary fungal infections in free-breathing mice
por: Vanherp, Liesbeth, et al.
Publicado: (2018)

Sensitive bioluminescence imaging of fungal dissemination to the brain in mouse models of cryptococcosis
por: Vanherp, Liesbeth, et al.
Publicado: (2019)

P412 QuicGM Aspergillus Galactomannan Ag lateral flow assay as a practical aid to diagnose invasive Aspergillosis in high-risk hematology patients
por: Aerts, Robina, et al.
Publicado: (2022)

Norepinephrine/oseltamivir: Lack of efficacy and invasive pulmonary aspergillosis secondary to off-label use: case report
Publicado: (2020)

International survey on influenza-associated pulmonary aspergillosis (IAPA) in intensive care units: responses suggest low awareness and potential underdiagnosis outside Europe
por: Thevissen, Karin, et al.
Publicado: (2020)

Correction to: International survey on influenza-associated pulmonary aspergillosis (IAPA) in intensive care units: responses suggest low awareness and potential underdiagnosis outside Europe
por: Thevissen, Karin, et al.
Publicado: (2020)

Genetic deficiency of NOD2 confers resistance to invasive aspergillosis
por: Gresnigt, Mark S., et al.
Publicado: (2018)

Increasing Incidence of Mucormycosis in University Hospital, Belgium
por: Saegeman, Veroniek, et al.
Publicado: (2010)

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
por: Verweij, Paul E., et al.
Publicado: (2021)

First Investigative Study of Azole-Resistant Aspergillus fumigatus in the Environment in Burkina Faso
por: Yerbanga, Isidore W., et al.
Publicado: (2021)

Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry
por: Prattes, Juergen, et al.
Publicado: (2021)

Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients
por: Hérivaux, Anaïs, et al.
Publicado: (2022)

Pulmonary Aspergillosis in Humboldt Penguins—Susceptibility Patterns and Molecular Epidemiology of Clinical and Environmental Aspergillus fumigatus Isolates from a Belgian Zoo, 2017–2022
por: Debergh, Hanne, et al.
Publicado: (2023)

Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers
por: Jang, Kyungho, et al.
Publicado: (2017)

Covid-19-Associated Pulmonary Aspergillosis: The Other Side of the Coin
por: Costantini, Claudio, et al.
Publicado: (2020)

Invasive Pulmonary Aspergillosis Goes Viral Again?
por: Wauters, Joost, et al.
Publicado: (2021)

Use of Next-Generation Sequencing for Diagnosis of West Nile Virus Infection in Patient Returning to Belgium from Hungary
por: Wollants, Elke, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k152u9ks09mbqs1ucma7lgor8g